Literature DB >> 30234409

Oxidative stress in chronic lymphocytic leukemia: still a matter of debate.

Giovanni D'Arena1, Elisa Seneca1, Ilaria Migliaccio1, Vincenzo De Feo2, Aldo Giudice3, Francesco La Rocca4, Mario Capunzo5, Gioacchino Calapai6, Agostino Festa7, Michele Caraglia7, Pellegrino Musto8, Eugenio Luigi Iorio9, Vitalba Ruggieri4.   

Abstract

There is a large body of evidence showing a strong correlation between carcinogenesis of several types of human tumors, including chronic lymphocytic leukemia (CLL), and oxidative stress (OS). The mechanisms by which OS may promote cancer pathogenesis have not been completely deciphered yet and, in CLL, as in other neoplasms, whether OS is a primary cause or simply a downstream effect of the disease is still an open question. It has been demonstrated that, in CLL, OS concomitantly results from increased reactive oxygen species (ROS) production, mainly ascribable to CLL cells mitochondrial activity, and impaired antioxidant defenses. Interestingly, OS evaluation in CLL patients, at diagnosis, seems to have a prognostic significance, thus getting new insights in the biological comprehension of the disease with potential therapeutic implications.

Entities:  

Keywords:  Chronic lymphocytic leukemia; oxidative stress; prognostication

Mesh:

Substances:

Year:  2018        PMID: 30234409     DOI: 10.1080/10428194.2018.1509317

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

1.  Effects of Ibrutinib on biophysical parameters of platelet in patients with chronic lymphocytic leukaemia.

Authors:  Viola Maria Popov; Christien Oktaviani Matei; Meilin Omer; Minodora Onisai; Mircea Bogdan Matei; Tudor Savopol; Horia Bumbea; Mihaela G Moisescu
Journal:  Am J Blood Res       Date:  2020-12-15

Review 2.  T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.

Authors:  Elisavet Vlachonikola; Kostas Stamatopoulos; Anastasia Chatzidimitriou
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

Review 3.  Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia.

Authors:  Mario Angelo Pagano; Federica Frezzato; Andrea Visentin; Livio Trentin; Anna Maria Brunati
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

Review 4.  cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies.

Authors:  Krzysztof Domka; Agnieszka Goral; Malgorzata Firczuk
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

5.  Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.

Authors:  Walaa Darwiche; Cathy Gomila; Hakim Ouled-Haddou; Marie Naudot; Cécile Doualle; Pierre Morel; Florence Nguyen-Khac; Loïc Garçon; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  J Exp Clin Cancer Res       Date:  2020-10-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.